Skip to NavigationSkip to content

News

AstraZeneca and MSD’s Lynparza has been approved for use in Europe, it has emerged, with the EMA awarding authorisation to the drug as a maintenance...
The FDA has approved the use of the combination of Tafinlar and Mekinist in the treatment of BRAF V600E mutation-positive anaplastic thyroid cancer...
Johnson & Johnson has revealed new data on its new depression drug esketamine, its chemically ‘left-handed’ version of the controlled...
Genmab and Janssen's combination of Darzalex with bortezomib, melphalan, and prednisone has received authorisation from the FDA for the treatment of...
AstraZeneca has confirmed it has signed a deal to jettison its schizophrenia drug Seroquel and its extended release version Seroquel XR to Chinese...
After more than a month of uncertainty, Takeda has finally confirmed it has managed to successfully acquire Shire, agreeing on a valuation of £46...
Check out the week's ten most popular articles on Pharmafile.com now!
The city of Los Angeles has levied legal action against a number of pharmaceutical firms for their role in advancing the ongoing US opioid crisis,...
Mallinckrodt paid $80 million, with a further $345 million dependent on milestones, to acquire InfaCare in the hope that the latter’s treatment for...
Our latest free webinar reflects on how best to implement the revised GVP module, in regards to risk management during the life-cycle of a medicine.
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches